204 related articles for article (PubMed ID: 34611230)
1. Temporalis muscle thickness as an indicator of sarcopenia predicts progression-free survival in head and neck squamous cell carcinoma.
Lee B; Bae YJ; Jeong WJ; Kim H; Choi BS; Kim JH
Sci Rep; 2021 Oct; 11(1):19717. PubMed ID: 34611230
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of head and neck computed tomography for skeletal muscle mass estimation in patients with head and neck cancer.
Jung AR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
Oral Oncol; 2019 Aug; 95():95-99. PubMed ID: 31345401
[TBL] [Abstract][Full Text] [Related]
3. Temporal muscle thickness is an independent prognostic marker in patients with progressive glioblastoma: translational imaging analysis of the EORTC 26101 trial.
Furtner J; Genbrugge E; Gorlia T; Bendszus M; Nowosielski M; Golfinopoulos V; Weller M; van den Bent MJ; Wick W; Preusser M
Neuro Oncol; 2019 Dec; 21(12):1587-1594. PubMed ID: 31369680
[TBL] [Abstract][Full Text] [Related]
4. Association between temporal muscle thickness and clinical outcomes in patients with newly diagnosed glioblastoma.
An G; Ahn S; Park JS; Jeun SS; Hong YK
J Cancer Res Clin Oncol; 2021 Mar; 147(3):901-909. PubMed ID: 32929611
[TBL] [Abstract][Full Text] [Related]
5. Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases.
Furtner J; Berghoff AS; Albtoush OM; Woitek R; Asenbaum U; Prayer D; Widhalm G; Gatterbauer B; Dieckmann K; Birner P; Aretin B; Bartsch R; Zielinski CC; Schöpf V; Preusser M
Eur Radiol; 2017 Aug; 27(8):3167-3173. PubMed ID: 28050694
[TBL] [Abstract][Full Text] [Related]
6. PET/CT Versus Standard Imaging for Prediction of Survival in Patients with Recurrent Head and Neck Squamous Cell Carcinoma.
Rohde M; Nielsen AL; Pareek M; Johansen J; Sørensen JA; Diaz A; Nielsen MK; Christiansen JM; Asmussen JT; Nguyen N; Gerke O; Thomassen A; Alavi A; Høilund-Carlsen PF; Godballe C
J Nucl Med; 2019 May; 60(5):592-599. PubMed ID: 30315144
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of body composition on recurrence and survival of advanced-stage head and neck cancer.
Jung AR; Roh JL; Kim JS; Kim SB; Choi SH; Nam SY; Kim SY
Eur J Cancer; 2019 Jul; 116():98-106. PubMed ID: 31185387
[TBL] [Abstract][Full Text] [Related]
8. Correlation of reduced temporal muscle thickness and systemic muscle loss in newly diagnosed glioblastoma patients.
Ten Cate C; Huijs SMH; Willemsen ACH; Pasmans RCOS; Eekers DBP; Zegers CML; Ackermans L; Beckervordersandforth J; van Raak EPM; Anten MHME; Hoeben A; Postma AA; Broen MPG
J Neurooncol; 2022 Dec; 160(3):611-618. PubMed ID: 36394717
[TBL] [Abstract][Full Text] [Related]
9. Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomes.
Marcus C; Ciarallo A; Tahari AK; Mena E; Koch W; Wahl RL; Kiess AP; Kang H; Subramaniam RM
J Nucl Med; 2014 Sep; 55(9):1411-6. PubMed ID: 24947059
[TBL] [Abstract][Full Text] [Related]
10. Circulating Tumor Cells Correlate With Prognosis in Head and Neck Squamous Cell Carcinoma.
Zhou S; Wang L; Zhang W; Liu F; Zhang Y; Jiang B; Wang J; Yuan H
Technol Cancer Res Treat; 2021; 20():1533033821990037. PubMed ID: 33641530
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of temporal muscle thickness, a novel radiographic marker of sarcopenia, in patients with brain tumor: A systematic review and meta-analysis.
Yang YW; Ming Yang ; Zhou YW; Xia X; Jia SL; Zhao YL; Zhou LX; Cao Y; Ge ML
Nutrition; 2023 Aug; 112():112077. PubMed ID: 37236042
[TBL] [Abstract][Full Text] [Related]
12. Reliability and validity of measuring temporal muscle thickness as the evaluation of sarcopenia risk and the relationship with functional outcome in older patients with acute stroke.
Nozoe M; Kubo H; Kanai M; Yamamoto M; Okakita M; Suzuki H; Shimada S; Mase K
Clin Neurol Neurosurg; 2021 Feb; 201():106444. PubMed ID: 33395619
[TBL] [Abstract][Full Text] [Related]
13. Prognostic relevance of temporal muscle thickness as a marker of sarcopenia in patients with glioblastoma at diagnosis.
Muglia R; Simonelli M; Pessina F; Morenghi E; Navarria P; Persico P; Lorenzi E; Dipasquale A; Grimaldi M; Scorsetti M; Santoro A; Politi LS
Eur Radiol; 2021 Jun; 31(6):4079-4086. PubMed ID: 33201284
[TBL] [Abstract][Full Text] [Related]
14. Sarcopenia and Systemic Inflammation Synergistically Impact Survival in Oral Cavity Cancer.
Lee J; Liu SH; Dai KY; Huang YM; Li CJ; Chen JC; Leu YS; Liu CJ; Chen YJ
Laryngoscope; 2021 May; 131(5):E1530-E1538. PubMed ID: 33135827
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Third Cervical Vertebra Skeletal Muscle Index in Oral Cavity Cancer: A Retrospective Study.
Chang SW; Hsu CM; Tsai YH; Chang GH; Tsai MS; Huang EI; Tsai YT
Laryngoscope; 2021 Jul; 131(7):E2257-E2265. PubMed ID: 33433021
[TBL] [Abstract][Full Text] [Related]
16. The possible relation between temporal muscle mass and glioblastoma multiforme prognosis via sarcopenia perspective.
Sütcüoğlu O; Erdal ZS; Akdoğan O; Çeltikçi E; Özdemir N; Özet A; Uçar M; Yazıcı O
Turk J Med Sci; 2023 Feb; 53(1):413-419. PubMed ID: 36945944
[TBL] [Abstract][Full Text] [Related]
17. A novel radiographic marker of sarcopenia with prognostic value in glioblastoma.
Huq S; Khalafallah AM; Ruiz-Cardozo MA; Botros D; Oliveira LAP; Dux H; White T; Jimenez AE; Gujar SK; Sair HI; Pillai JJ; Mukherjee D
Clin Neurol Neurosurg; 2021 Aug; 207():106782. PubMed ID: 34186275
[TBL] [Abstract][Full Text] [Related]
18. Quantitative muscle mass biomarkers are independent prognosis factors in primary central nervous system lymphoma: The role of L3-skeletal muscle index and temporal muscle thickness.
Leone R; Sferruzza G; Calimeri T; Steffanoni S; Conte GM; De Cobelli F; Falini A; Ferreri AJM; Anzalone N
Eur J Radiol; 2021 Oct; 143():109945. PubMed ID: 34492625
[TBL] [Abstract][Full Text] [Related]
19. Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071-22072 and CORE Trials.
Furtner J; Weller M; Weber M; Gorlia T; Nabors B; Reardon DA; Tonn JC; Stupp R; Preusser M;
Clin Cancer Res; 2022 Jan; 28(1):129-136. PubMed ID: 34667022
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of sarcopenia as a prognostic biomarker in locally advanced head and neck squamous cell carcinoma.
Erul E; Guven DC; Ozbay Y; Altunbulak AY; Kahvecioglu A; Ercan F; Yesil MF; Ucdal MT; Cengiz M; Yazici G; Kuscu O; Suslu N; Gullu I; Onur MR; Aksoy S
Biomark Med; 2023 Jan; 17(2):87-99. PubMed ID: 37042459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
